Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: Further evidence of a spatial code for BDNF splice variants

Neuropsychopharmacology

Volumn 37, Issue 7, 2012, Pages 1600-1611

  Baj, Gabriele ^a   D'Alessandro, Valentina ^a   Musazzi, Laura ^b   Mallei, Alessandra ^b   Sartori, Cesar R ^c   Sciancalepore, Marina ^a   Tardito, Daniela ^b   Langone, Francesco ^c   Popoli, Maurizio ^b   Tongiorgi, Enrico ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

antidepressants; dendritic mRNA trafficking; depression; hippocampus; neurotrophins; physical exercise

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE; MESSENGER RNA; NORADRENALIN; REBOXETINE; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; EXERCISE; EXON; GENETIC VARIABILITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPAL STRATUM LUCIDUM; IMMUNOFLUORESCENCE; MALE; MOUSE; NERVE CELL EXCITABILITY; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RUNNING; STRATUM PYRAMIDALE; STRATUM RADIATUM; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CA3 REGION, HIPPOCAMPAL; CELLS, CULTURED; DENDRITES; FLUOXETINE; MALE; MICE; MORPHOLINES; NEURONS; NOREPINEPHRINE; PHYSICAL CONDITIONING, ANIMAL; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 84861199485     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.5     Document Type: Article

References (57)

1. Adachi M, Barrot M, Autry AE, Theobald D, Monteggia LM (2008). Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry 63: 642-649. (Pubitemid 351329281)
2. Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007). Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85: 525-535.
3. Aliaga EE, Mendoza I, Tapia-Arancibia L (2009). Distinct subcellular localization of BDNF transcripts in cultured hypothalamic neurons and modification by neuronal activation. J Neural Transm 116: 23-32.
4. Baj G, Leone E, Chao MV, Tongiorgi E (2011). Spatial segregation of BDNF transcripts enables BDNF to differentially shape distinct dendritic compartments. Proc Natl Acad Sci USA 108: 16813-16818.
5. Binder DK, Routbort MJ, McNamara JO (1999). Immunohistochemical evidence of seizure-induced activation of trk receptors in the mossy fiber pathway of adult rat hippocampus. J Neurosci 19: 4616-4626. (Pubitemid 29241109)
6. Bjornebekk A, Mathe AA, Brene S (2005). The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int J Neuropsychopharmacol 8: 357-368. (Pubitemid 41002490)
7. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G et al. (2007). Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32: 2351-2359. (Pubitemid 47587673)
8. Capsoni S, Tongiorgi E, Cattaneo A, Domenici L (1999). Differential regulation of brain-derived neurotrophic factor messenger RNA cellular expression in the adult rat visual cortex. Neuroscience 93: 1033-1040. (Pubitemid 29341650)
9. Castren E (2004). Neurotrophic effects of antidepressant drugs. Curr Opin Pharmacol 4: 58-64. (Pubitemid 38145839)
10. Castren E, Rantamaki T (2010). The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 70: 289-297.
11. Chiaruttini C, Sonego M, Baj G, Simonato M, Tongiorgi E (2008). BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae. Mol Cell Neurosci 37: 11-19. (Pubitemid 350299994)
12. Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S (2010). Brainderived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 70: 271-288.
13. Conrad CD (2006). What is the functional significance of chronic stress-induced CA3 dendritic retraction within the hippocampus? Behav Cogn Neurosci Rev 5: 41-60. (Pubitemid 43987740)
14. Cotman CW, Berchtold NC (2002). Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25: 295-301. (Pubitemid 34667010)
15. Danzer SC, Crooks KR, Lo DC, McNamara JO (2002). Increased expression of brain-derived neurotrophic factor induces formation of basal dendrites and axonal branching in dentate granule cells in hippocampal explant cultures. J Neurosci 22: 9754-9763. (Pubitemid 35332858)
16. Dias BG, Banerjee SB, Duman RS, Vaidya VA (2003). Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacology 45: 553-563. (Pubitemid 36936988)
17. Dow AL, Russell DS, Duman RS (2005). Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: effects in behavioral models. J Neurosci 25: 4908-4916. (Pubitemid 40712834)
18. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
19. Garzon DJ, Fahnestock M (2007). Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J Neurosci 27: 2628-2635. (Pubitemid 46393608)
20. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391: 85-100. (Pubitemid 11012976)
21. Hughes IE, Smith JA (1978). The stability of noradrenaline in physiological saline solutions. J Pharm Pharmacol 30: 124-126. (Pubitemid 8268660)
22. Ivy AS, Rodriguez FG, Garcia C, Chen MJ, Russo-Neustadt AA (2003). Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant. Pharmacol Biochem Behav 75: 81-88. (Pubitemid 36577583)
23. Jeanneteau F, Deinhardt K, Miyoshi G, Bennett AM, Chao MV (2010). The MAP kinase phosphatase MKP-1 regulates BDNFinduced axon branching. Nat Neurosci 13: 1373-1379.
24. Kuczewski N, Porcher C, Lessmann V, Medina I, Gaiarsa JL (2009). Activity-dependent dendritic release of BDNF and biological consequences. Mol Neurobiol 39: 37-49.
25. Ma Q (2008). Beneficial effects of moderate voluntary physical exercise and its biological mechanisms on brain health. Neurosci Bull 24: 265-270.
26. Magarinos AM, Li CJ, Gal Toth J, Bath KG, Jing D, Lee FS et al. (2011). Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons. Hippocampus 21: 253-264.
27. Martinez A, Alcantara S, Borrell V, Del Rio JA, Blasi J, Otal R et al. (1998). TrkB and TrkC signaling are required for maturation and synaptogenesis of hippocampal connections. J Neurosci 18: 7336-7350. (Pubitemid 28425818)
28. Megias M, Emri Z, Freund TF, Gulyas AI (2001). Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 102: 527-540. (Pubitemid 32171874)
29. Molteni R, Calabrese F, Bedogni F, Tongiorgi E, Fumagalli F, Racagni G et al. (2006). Chronic treatment with fluoxetine upregulates cellular BDNF mRNA expression in rat dopaminergic regions. Int J Neuropsychopharmacol 9: 307-317. (Pubitemid 43780498)
30. Palop JJ, Roberson ED, Cobos I (2011). Step-by-step in situ hybridization method for localizing gene expression changes in the brain. Methods Mol Biol 670: 207-230.
31. Pattabiraman PP, Tropea D, Chiaruttini C, Tongiorgi E, Cattaneo A, Domenici L (2005). Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo. Mol Cell Neurosci 28: 556-570. (Pubitemid 40311858)
32. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T (2007). Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90: 397-406. (Pubitemid 47179877)
33. Pruunsild P, Sepp M, Orav E, Koppel I, Timmusk T (2011). Identification of cis-elements and transcription factors regulating neuronal activity-dependent transcription of human BDNF gene. J Neurosci 31: 3295-3308.
34. Righi M, Tongiorgi E, Cattaneo A (2000). Brain-derived neurotrophic factor (BDNF) induces dendritic targeting of BDNF and tyrosine kinase B mRNAs in hippocampal neurons through a phosphatidylinositol-3 kinase-dependent pathway. J Neurosci 20: 3165-3174. (Pubitemid 30263133)
35. Russo-Neustadt A, Beard RC, Cotman CW (1999). Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21: 679-682. (Pubitemid 29486636)
36. Russo-Neustadt AA, Alejandre H, Garcia C, Ivy AS, Chen MJ (2004). Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 29: 2189-2199. (Pubitemid 39578909)
37. Russo-Neustadt AA, Chen MJ (2005). Brain-derived neurotrophic factor and antidepressant activity. Curr Pharm Des 11: 1495-1510. (Pubitemid 40691448)
38. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E et al. (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23: 349-357. (Pubitemid 36050437)
39. Sakata K, Woo NH, Martinowich K, Greene JS, Schloesser RJ, Shen L et al. (2009). Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex. Proc Natl Acad Sci USA 106: 5942-5947.
40. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805-809. (Pubitemid 36962615)
41. Smith MA, Zhang LX, Lyons WE, Mamounas LA (1997). Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport 8: 1829-1834. (Pubitemid 27314292)
42. Steward O, Schuman EM (2001). Protein synthesis at synaptic sites on dendrites. Annu Rev Neurosci 24: 299-325. (Pubitemid 32695231)
43. Swanger SA, Bassell GJ, Gross C (2011). High-resolution fluorescence in situ hybridization to detect mRNAs in neuronal compartments in vitro and in vivo. Methods Mol Biol 714: 103-123.
44. Taliaz D, Stall N, Dar DE, Zangen A (2010). Knockdown of brainderived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry 15: 80-92.
45. Tanti A, Belzung C (2010). Open questions in current models of antidepressant action. Br J Pharmacol 159: 1187-1200.
46. Tardito D, Musazzi L, Tiraboschi E, Mallei A, Racagni G, Popoli M (2009). Early induction of CREB activation and CREB-regulating signalling by antidepressants. Int J Neuropsychopharmacol 12: 1367-1381.
47. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M (2006). Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58: 115-134.
48. Tongiorgi E (2008). Activity-dependent expression of brainderived neurotrophic factor in dendrites: facts and open questions. Neurosci Res 61: 335-346.
49. Tongiorgi E, Armellin M, Giulianini PG, Bregola G, Zucchini S, Paradiso B et al. (2004). Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis. J Neurosci 24: 6842-6852. (Pubitemid 38993907)
50. Tongiorgi E, Righi M, Cattaneo A (1997). Activity-dependent dendritic targeting of BDNF and TrkB mRNAs in hippocampal neurons. J Neurosci 17: 9492-9505. (Pubitemid 28006394)
51. Tongiorgi E, Righi M, Cattaneo A (1998). A non-radioactive in situ hybridization method that does not require RNAse-free conditions. J Neurosci Methods 85: 129-139. (Pubitemid 29003063)
52. Trivedi MH, Greer TL, Grannemann BD, Chambliss HO, Jordan AN (2006). Exercise as an augmentation strategy for treatment of major depression. J Psychiatr Pract 12: 205-213. (Pubitemid 44180543)
53. Vaynman S, Ying Z, Gomez-Pinilla F (2004). Exercise induces BDNF and synapsin I to specific hippocampal subfields. J Neurosci Res 76: 356-362. (Pubitemid 38580130)
54. Wood GE, Young LT, Reagan LP, Chen B, McEwen BS (2004). Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc Natl Acad Sci USA 101: 3973-3978. (Pubitemid 38381087)
55. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM (2009). The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 14: 51-59.
56. Yau SY, Lau BW, Tong JB, Wong R, Ching YP, Qiu G et al. (2011). Hippocampal neurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed rats. PLoS One 6: e24263.
57. Yoshii A, Constantine-Paton M (2010). Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol 70: 304-322.